Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 18, 2017
Pfizer CentreOne announced that it is now offering services in Nagoya, Japan.
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
Tuesday, October 24, 2017
Catalent has completed the acquisition of Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services.
read more
Tuesday, October 24, 2017
A newly released modeling study conducted by The Tufts CSDD finds that sponsors who employ single-source outsourcing partners, versus a multivendor development and manufacturing model, experience significant financial benefits.
read more
Tuesday, October 24, 2017
Cambrex announced the completion of an expansion to its large scale production capacity at its Iowa plant.
read more
Thursday, October 26, 2017
Achieve Life Sciences has entered into an exclusive supply agreement with Sopharma AD for the manufacture of cytisine API and finished tablets.
read more
Catalent Pharma Solutions has signed a multi-year agreement with Grid Therapeutics, for the development and manufacture of Grid’s lead therapeutic candidate for the treatment of solid tumors.
read more
Tuesday, October 31, 2017
Sawai has entered into an exclusive agreement with AstraZeneca to manufacture and market Zomig Tablets Zomig Rapid Melt Tablets, a migraine medication in Japan.
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Wednesday, November 01, 2017
Capsugel announced expanded clinical trial capabilities at its Edinburgh facility in Scotland.
read more
Wednesday, November 01, 2017
The FDA has determined the agency will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities that meet FDA requirements.
read more
Wednesday, November 01, 2017
Lannett has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S. related to Celgene's Thalomid.
read more
Wednesday, November 01, 2017
MilliporeSigma announced the signing of a MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
read more
Monday, November 06, 2017
FUJIFILM is to invest a total of 3.2 billion yen on its CDMO sites in the U.S. and the U.K. in order to accelerate the expansion of the company's business for developing and manufacturing biopharmaceuticals under contract for other parties.
read more
Monday, November 06, 2017
InVitria has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany.
read more